Left colon cancer pt.1 Flashcards

1
Q

Where does colon cancer rank globally in cancer frequency

A

Colorectal cancer is third globally in cancer incidence and cancer death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In which portions of the colorectum does cancer arise?

A
  • About 70 % in colon (About 25% in right and 35% in left)
  • By portion: Cecum 14 %, Ascending colon 10 %, Transverse colon 12 %, Descending colon 7 %, Sigmoid colon 25 %, Rectum 23 %
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Age and incidence of colorectal cancer

A

Large bowel cancer is uncommon before the age of 40; the incidence begins to increase significantly between the ages of 40 and 50, and age-specific incidence rates increase in each succeeding decade thereafter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sporadic vs familial cases of colon cancer

A

Majority of CRCs are sporadic rather than familial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors for developing colon cancer

A
  • Environmental and genetic factors can increase the likelihood of developing CRC
  • Factors can be divided into ones that influence screening recommendations and ones that don’t
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are factors that currently influence screening recommendations for colorectal cancer?

A

CRC screening recommendations are modified for members of families with hereditary colon cancer syndromes, on the basis of personal or family history of CRC or adenomas (Up to 25% of patients with colorectal cancer have a family history of
the disease), in patients with inflammatory bowel disease, and in those who have been exposed to abdominal radiation therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which familial syndromes are associated with a high risk of developing colorectal cancer? How much do they contribute to the total number of colorectal cancer?

A
  • Familial adenomatous polyposis (FAP, aka polyposis coli) and Lynch syndrome (hereditary nonpolyposis colorectal cancer [HNPCC]) are the most common of the familial colon cancer syndromes, but together these two conditions account for only approximately 5 percent of CRC cases, the majority of which are Lynch syndrome
  • MYH-associated polyposis (MAP) can also lead to it but is rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which IBDs are associated with an increased risk of colorectal cancer?

A
  • Ulcerative colitis (more so than CD)
  • Chron’s disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Screening age recommendation for colorectal cancer

A
  • ACG (American college of Gastroenterology) and US Preventive Services Task Force (USPSTF) recommended that average-risk patients over the age of 45 years be screened for CRC
  • Initiating screening at age 50 years for average-risk adults is recommended by the Canadian Task Force on Preventive Health Care (CTFPHC), the European Council, the American Academy of Family Physicians (AAFP), and the American College of Physicians (ACP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sex and colorectal cancer

A
  • Rates of both incidence and mortality are substantially higher in males than in females
  • CRC mortality is approximately 33 percent higher in males than in females
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Protective factors for colon cancer

A

These include regular physical activity, a variety of dietary factors (diet high in fruits and vegetables, resistant starch, Vitamin D, antioxidants), and the regular use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Impact of race on CRC

A
  • Black Americans, Native Americans, and Alaskan Native individuals have among the highest incidence and mortality rates for CRC of all racial and ethnic groups in the United States
  • In addition, CRCs occur at a younger age, as there is a higher frequency of CRC under age 50 in these populations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are factors that currently don’t influence screening recommendations for colorectal cancer?

A
  • There are a large number of clinical, environmental, and lifestyle factors that are associated with a small and/or uncertain increased risk of CRC
  • Although many of these associations have been seen consistently in observational studies, the causal relationship of these associations is largely unproven
  • Patients may be counseled about these associations and encouraged to reduce or avoid such factors for the primary prevention of CRC.
  • These include obesity, diabetes, processed meats (red meat might have an impact but less than processed meats), alcohol use, smoking, Cholecystectomy, Streptococcus bovis bacteremia, acromegaly, use of androgen deprivation therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do patients with CRC present to the clinic?

A

Patients with CRC may present in three ways:
●Suspicious symptoms and/or signs
●Asymptomatic individuals discovered by routine screening
●Emergency admission with intestinal obstruction, perforation, or rarely, an acute gastrointestinal bleed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the symptoms of CRC?

A
  • There are no symptoms in the majority of patients with early-stage colon cancer and these patients are diagnosed as a result of screening
  • Symptoms of CRC are typically due to growth of the tumor into the lumen or adjacent structures, and as a result, symptomatic presentation usually reflects relatively advanced CRC
  • Typical symptoms/signs associated with CRC include hematochezia (more often caused by rectosigmoid than right-sided colon cancer) or melena, abdominal pain, otherwise unexplained iron deficiency anemia (more often right-sided CRC), and/or a change in bowel habit (more often in left than right CRC) (e.g. constipation)
  • Unspecific symptoms such as weight loss and weakness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stats about when CRC is usually diagnosed?

A
  • Most CRCs (70 to 90 percent in two contemporary series) are diagnosed after the onset of symptoms
  • Up to 20% of patients have distant metastatic disease at the time of
    presentation
17
Q

Symptoms of left colon cancer

A
  • Constipation
  • Alternating bowel patterns
  • Abdominal pain,
  • Narrowed stool caliber
  • Tenesmus
  • Rectal bleeding
  • Bright Red Blood per Rectum
  • Large Bowel Obstruction
18
Q

Symptoms of right colon cancer

A
  • Lesions of the right colon commonly ulcerate, leading to chronic, insidious blood loss without a change in the appearance of the stool
  • Consequently, patients with tumors of the ascending colon often present with symptoms such as fatigue, palpitations, and even angina pectoris and are found to have a hypochromic, microcytic anemia, indicative of iron
    deficiency
  • Weight loss
  • Rarely obstruction
19
Q

Symptoms of rectal cancer

A

Obstruction, tenesmus, bleedingPalpable mass on rectal exam, bright Red Blood Per Rectum

20
Q

What is hematochezia?

A

The passage of fresh blood per anus, usually in or with stools

21
Q

What is tenesmus?

A

A repeated, painful urge to defecate without excreting stool

22
Q

Origin of CRC

A

Most colorectal cancers (CRCs) originate from adenomatous polyps or flat dysplasia

23
Q

Morphology of CRCs

A
  • Gross appearances depend on location
  • Tumors in the proximal or right colon usually appear grossly as polypoid (resembling or in the form of a polyp) or fungating (looking like a fungus) exophytic (arising from the outer surface of the organ of origin) masses
  • Tumors involving the distal or left colon are more commonly annular (ring-shaped) or encircling lesions that produce an “apple-core” or “napkin-ring” appearance
  • Right- and left-sided colon cancers are microscopically similar
24
Q

Type of carcinoma found in CRC

A
  • Of the carcinomas, more than 90 percent are adenocarcinomas
  • Other histologic types of tumors (neuroendocrine neoplasms, hamartomas, mesenchymal tumors, lymphomas) are relatively unusual
25
Q

What are some mutations associated with colorectal cancer development?

A
  • APC, K-ras, P53
  • COX2 overexpression is associated with furthering development
26
Q

How many polyps become carcinomas in the colorectum?

A
  • Less than 1%
  • The likelihood that any polypoid lesion in the large bowel contains invasive cancer is related to the size of the polyp, being negligible (<2%) in lesions <1.5 cm, intermediate (2–10%) in lesions 1.5–2.5 cm, and substantial (10%) in lesions >2.5 cm in size
27
Q

What is a polyp?

A

A grossly visible protrusion from the mucosal surface

28
Q

What can polyps be classified into?

A
  • May be classified pathologically as a nonneoplastic hamartoma (e.g., juvenile polyp), a hyperplastic mucosal proliferation (hyperplastic polyp), or an adenomatous polyp
  • Polyps may be pedunculated (stalked) or sessile (flat-based), adenomatous or serrated (notched like the cutting edge of a saw)
  • Histologically, adenomatous polyps may be tubular, villous (i.e., papillary), or tubulovillous
29
Q

Which types of polyps are more likely to cause malignancy?

A
  • Only adenomas are clearly premalignant
  • Invasive cancers develop more
    frequently in sessile, serrated (i.e., “flat”) polyps
  • Villous adenomas, most of which are sessile, become malignant more than three times as often as tubular adenomas
30
Q

How many polyps are expected to be found in a person?

A
  • Adenomatous polyps may be found in the colons of ~30% of middle-aged and ~50% of elderly people
  • Such patients have a 30–50% probability of developing another adenoma and are at a higher-than-average risk for developing a colorectal carcinoma
  • Following the detection of an adenomatous polyp, the entire large bowel should be visualized endoscopically because synchronous lesions are noted in about one-third of cases
31
Q

T description for colorectal cancer

A
  • T1 no deeper than submucosa
  • T2 Invades muscularis propria
  • T3 Penetrates through muscularis and invades subserosa (involving serosa and/or mesorectal or pericolic fat)
  • T4 Invades peritoneal reflection (visceral peritoneum) (T4a) or other organs (T4b)
32
Q

N description for colorectal cancer

A
  • N1 invades 1-3 perirectal or pericolic lymph nodes
  • N2 invades 4+ pericolic or perirectal lymph nodes
33
Q

M description for colorectal cancer

A

M1 distant metastasis

34
Q

Clinical staging based on TNM

A

T1-T2 N0 M0 stage 1
T3-4 N0 M0 stage 2
Any T Any N1-N2 M0 stage 3
Any T Any N M1 is stage 4

35
Q

How many lymph nodes should be sampled for staging of colorectal cancer

A

A minimum of 12 sampled lymph nodes is thought necessary to accurately define tumor stage, and the more nodes examined, the better.